BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2968150)

  • 41. Anaplastic small cell neoplasms of the thyroid: an immunoperoxidase study.
    Mambo NC; Irwin SM
    Hum Pathol; 1984 Jan; 15(1):55-60. PubMed ID: 6319268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Carcinoma of the thyroid gland with biphasic clinical course and evolution into medullary carcinoma, follicular variant. A case report and immunocytochemical demonstration of the simultaneous presence of calcitonin and thyroglobulin in neoplastic cells].
    Carlei F; Famulari A; Muzi P; Sciaratta F; Mariani P; Lomanto D; D'Alessandro M
    Minerva Chir; 1992 Apr; 47(8):773-5. PubMed ID: 1603426
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphoid and epithelial markers in small cell anaplastic thyroid tumours.
    Burt AD; Kerr DJ; Brown IL; Boyle P
    J Clin Pathol; 1985 Aug; 38(8):893-6. PubMed ID: 2993371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medullary (C cell) carcinoma of the thyroid with features of follicular oxyphilic cell tumours.
    Harach HR; Bergholm U
    Histopathology; 1988 Dec; 13(6):645-56. PubMed ID: 2466753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
    Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma.
    Wiseman SM; Griffith OL; Deen S; Rajput A; Masoudi H; Gilks B; Goldstein L; Gown A; Jones SJ
    Arch Surg; 2007 Aug; 142(8):717-27; discussion 727-9. PubMed ID: 17709725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of immunoperoxidase techniques on paraffin embedded tissue in determining the histogenesis of undifferentiated thyroid neoplasms.
    Myskow MW; Krajewski AS; Dewar AE; Millar EP; McLaren K; Fabre JW
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):335-41. PubMed ID: 2423275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential value of the demonstration of thyroglobulin by immunoperoxidase techniques in fine needle aspiration cytology.
    Gal R; Aronof A; Gertzmann H; Kessler E
    Acta Cytol; 1987; 31(6):713-6. PubMed ID: 2447717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroglobulin immunoreactivity in lymph node histiocytes: a potential diagnostic pitfall.
    Venkatraman L; Maxwell P; McCluggage WG
    J Clin Pathol; 2001 Apr; 54(4):314-6. PubMed ID: 11304850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
    Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
    Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland.
    Ramos-Vara JA; Miller MA; Johnson GC; Pace LW
    Vet Pathol; 2002 Jul; 39(4):480-7. PubMed ID: 12126151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical staining for thyroglobulin in poorly differentiated carcinoma of the thyroid.
    Ratnatnga N; Ramadasa S
    Ceylon Med J; 1993 Sep; 38(3):113-6. PubMed ID: 7828228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers].
    Brasanac D; Jancić-Zgurics M; Janković R; Tatić S
    Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
    Pacini F; Basolo F; Elisei R; Fugazzola L; Cola A; Pinchera A
    Am J Clin Pathol; 1991 Mar; 95(3):300-8. PubMed ID: 1996540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid.
    Sobrinho-Simões M; Nesland JM; Johannessen JV
    Am J Clin Pathol; 1988 Feb; 89(2):264-7. PubMed ID: 3341287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medullary carcinoma of the thyroid gland: an immunocytochemical study.
    Holm R; Sobrinho-Simões M; Nesland JM; Gould VE; Johannessen JV
    Ultrastruct Pathol; 1985; 8(1):25-41. PubMed ID: 3901454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.
    Lam KY; Lo CY; Chan KW; Wan KY
    Ann Surg; 2000 Mar; 231(3):329-38. PubMed ID: 10714625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The localization of cytoskeletal proteins and thyroglobulin in thyroid microcarcinoma in comparison with clinically manifested thyroid carcinoma.
    Yagi Y; Yagi S; Saku T
    Cancer; 1985 Oct; 56(8):1967-71. PubMed ID: 2411384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
    Kavishwar VS; Phatak AM; Rege JD
    Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma.
    Noel M; Delehaye MC; Segond N; Lasmoles F; Caillou B; Gardet P; Fragu P; Moukhtar MS
    Thyroid; 1991; 1(3):249-56. PubMed ID: 1824340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.